CD4 and hepatocellular carcinoma: In HCC, the median percentage of CD4+ T cells and CD8+ T cells were 40.95% (1.15%-82.6%) and 22.7% (0.35%-56.9%), and the CD4/CD8 ratio was 1.7 (0.56-71.29).